These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 10191854)

  • 21. FDA approval: maraviroc.
    Sax PE
    AIDS Clin Care; 2007 Sep; 19(9):75. PubMed ID: 18398993
    [No Abstract]   [Full Text] [Related]  

  • 22. Regulatory issues and challenges in salvage therapy.
    Delaney M
    Res Initiat Treat Action; 2004; 10(1):29-30. PubMed ID: 15595171
    [No Abstract]   [Full Text] [Related]  

  • 23. An overview of the drug approval process.
    Martinez LJ
    Res Initiat Treat Action; 2002; 8(1):11-7. PubMed ID: 12489521
    [No Abstract]   [Full Text] [Related]  

  • 24. FDA notifications. Reyataz is approved for HIV treatment.
    AIDS Alert; 2003 Sep; 18(9):119-20. PubMed ID: 14686309
    [TBL] [Abstract][Full Text] [Related]  

  • 25. FDA notifications. Generic efavirenz/emtricitabine/fenofovir has tentative approval.
    AIDS Alert; 2009 Oct; 24(10):119-20. PubMed ID: 20034141
    [No Abstract]   [Full Text] [Related]  

  • 26. Accelerated approval: where are we now?
    Delaney M
    Res Initiat Treat Action; 2002; 8(1):18-22. PubMed ID: 12489522
    [No Abstract]   [Full Text] [Related]  

  • 27. T-20 (Fuzeon) gets priority review.
    AIDS Treat News; 2002 Oct; (384):4-5. PubMed ID: 12434762
    [No Abstract]   [Full Text] [Related]  

  • 28. FDA grants tentative approval to first generic version of antiretroviral Viread.
    AIDS Patient Care STDS; 2008 Jan; 22(1):86. PubMed ID: 18453039
    [No Abstract]   [Full Text] [Related]  

  • 29. Risk versus risk: decision-making dilemmas of drug regulation in the United States and Germany.
    Daemmrich A; Krucken G
    Sci Cult (Lond); 2000 Dec; 9(4):505-34. PubMed ID: 15988846
    [No Abstract]   [Full Text] [Related]  

  • 30. Long path to approval. A look back at the road to Fuzeon.
    GMHC Treat Issues; 2003 Mar; 17(3):1-5. PubMed ID: 12728856
    [No Abstract]   [Full Text] [Related]  

  • 31. A look ahead at this year's drug approvals.
    Proj Inf Perspect; 2007 Apr; (43):4-7. PubMed ID: 17684824
    [No Abstract]   [Full Text] [Related]  

  • 32. Tenofovir: FDA hearing October 3, public comment deadlines September 26.
    James JS
    AIDS Treat News; 2001 Aug; (370):3-4. PubMed ID: 11570163
    [No Abstract]   [Full Text] [Related]  

  • 33. Generic stavudine approved.
    AIDS Patient Care STDS; 2009 May; 23(5):396-7. PubMed ID: 19422067
    [No Abstract]   [Full Text] [Related]  

  • 34. European Commission approves Atripla.
    AIDS Patient Care STDS; 2008 Jan; 22(1):87-8. PubMed ID: 18453042
    [No Abstract]   [Full Text] [Related]  

  • 35. Maraviroc approved in the European Union.
    AIDS Patient Care STDS; 2007 Oct; 21(10):779. PubMed ID: 17992719
    [No Abstract]   [Full Text] [Related]  

  • 36. Emerging drugs in the fight against HIV disease.
    Rosenthal E
    HRSA Careaction; 2003 Feb; ():1-8. PubMed ID: 12739497
    [No Abstract]   [Full Text] [Related]  

  • 37. Indian company seeks US approval for generic AIDS drugs.
    Nature; 2004 Aug; 430(7001):716. PubMed ID: 15306779
    [No Abstract]   [Full Text] [Related]  

  • 38. Integration of salvage research into existing networks and structures.
    Evans D
    Res Initiat Treat Action; 2004; 10(1):22-3. PubMed ID: 15595168
    [No Abstract]   [Full Text] [Related]  

  • 39. 100th HIV/AIDS antiretroviral drug approved by PEPFAR.
    AIDS Patient Care STDS; 2009 Nov; 23(11):988-9. PubMed ID: 19938372
    [No Abstract]   [Full Text] [Related]  

  • 40. Maraviroc--new HIV drug. Emerging options need to be used wisely.
    Vázquez E
    Posit Aware; 2007; 18(4):18-9. PubMed ID: 17682275
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.